Astronics Corp (ATRO) 2009 Q2 法說會逐字稿

Greetings and welcome to the Astronics Corporation's second-quarter 2009 earnings conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions). As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Deborah Pawlowski, IR for Astronics Corporation. Thank you, Ms. Pawlowski, you may begin.

Thank you, Everett and good afternoon, everyone. We appreciate your time and interest in Astronics. On our call today is Pete Gundermann, President and CEO; and Dave Burney, Chief Financial Officer. Also joining us is Mark Peabody, the Executive Vice President with Astronics. He is joining us from Seattle.

We will be covering the results, outlook and prospects for the Company on the call and then follow it with a Q&A period. You should have the release that went out this morning and if not, it is available on the Company's website at Astronics.com.

As you are aware, we may make some forward-looking statements during the formal presentation and the question-and-answer portion of this teleconference. These statements apply to future events, which are subject to risks and uncertainties, as well as other factors that could cause the actual results to differ materially from where we are today. These factors are outlined in our earnings release, as well as in documents filed by the Company with the Securities and Exchange Commission. They can also be found at the SEC website, SEC.gov. So with that, let me turn it over to Pete to start the discussion. Peter?

Thank you and good afternoon, everybody. I am going to talk through our overall financial results for the quarter and for year-to-date and then turn it over to Dave for some specifics on our income statement and balance sheet. And then I'm going to take it back and talk through some of the happenings in our segments and productlines and then end the discussion with our revenue forecast and our expectations for the remainder of the year before we turn it over to questions-and-answers.

I guess our feeling is that the second quarter overall was a reasonable quarter given that the market conditions we faced, which continue to be pretty challenging and pretty dynamic. Our revenues in the second quarter were $47 million. They are down 1.8% from the second quarter of last year of 2008 when we had revenues of $47.9 million.

A couple of big caveats when we make comparisons though to last year. The first is that last year, the first half of 2008 in particular, was in many respects a very different world. The aerospace world at that point was not at all in the throes of the worldwide economic crisis that ensued subsequently. And the second quarter, in particular, for our Company was one of the strongest we have ever had. I think it was our second best revenue quarter ever even today and our most profitable and highest booking quarter. So comparisons have to be taken with that consideration in mind.

The other obvious change that has happened since then is we made the acquisition in January of DME Corporation. I'm going to talk about that on and off throughout this call. But obviously our results today are benefited from the acquisition that we made. So if you were to back out that acquisition and look at just organic sales performance in the second quarter of 2009 versus 2008, organic sales were $34.3 million in the quarter just finished, down 28%. So the math tells you that consolidated DME sales were $12.7 million for the second quarter. Together, we were down just marginally from our organic sales in the second quarter of 2008.

Our net profits were $2 million for the most recently concluded quarter compared to $5.1 million in the second quarter of 2008, $0.18 per diluted share versus $0.48 per diluted share. One wrinkle in our income statement is that we reversed a $900,000 contingent liability associated with the acquisition of DME based on our outlook for the end of the year and I will let Dave talk about that more specifically in a few minutes. But that benefited our earnings in the most recent period.

My way of looking at the business is that the first quarter of the year is a more relevant comparator because the first quarter and the second quarter were largely in the same market conditions. And in that comparison, our revenues were down in the second quarter $3 million or 6%, $47 million again versus $50 million in the first quarter. Our net income was up slightly, up $550,000, $1.9 million total versus $1.4 million total, $0.18 a share versus $0.13 per share. Again, the most recent quarter benefiting from the reversal of the contingency.

For the first half, sales were $97 million versus $89 million in the first half of '08, up 9%. DME consolidated sales contributed $24.3 million to that total. So organic was $72.7 million, again, down 18% from what we did last year if we hadn't done the DME acquisition.

Net income for the first half was $3.4 million versus $7.8 million last year, $0.31 per diluted share versus $0.73 per diluted share. Bookings were $40.8 million in the quarter just concluded. That is down from the year-ago quarter of $52.4 million, but up from the first quarter of this year when it was $30.8 million. Again, I think that bounciness tells you a little bit about the market conditions we faced to have $52 million in bookings in the second quarter of last year, dropping down to $30 million in the first quarter of this year, back up towards some range of what we hope is normalcy of $40 million. It gives you an idea of the lumpiness that we are facing right now.

Our backlog at the end of the second quarter was $105 million at current run rates. That is about six months of shipments and all things considered, we view that as a pretty comfortable backlog level. I will turn it over to Dave now for a couple of other comments and some of the details.

Thanks, Pete. Adding to some of Pete's comments, I want to color a few financial points. First, looking at our income statement for the quarter, you will notice other income of $900,000. This reflects the adjustment required by FASB statement 141(R) to adjust our $2 million contingent note payable relating to the purchase of DME to market value.

At this point, we view the probability of reaching the 2009 revenue target triggering, the earnout is not very likely to happen. As a result, we removed most of the note from our balance sheet and the accounting guidance tells us that the reduction in market value of this debt should be recorded as income. In prior years, before 141(R), you would have taken this type of an adjustment off of the goodwill that you put on your balance sheet when you made the acquisition, but that is not the way the FASB 141(R) tells us to do it this year.

Secondly, our effective tax rate for the quarter was on the lower end of where we typically are. It was 28%. This was due to the impact of recording R&D tax credits during the quarter. Looking forward, we expect that our effective tax rate for the 2009 calendar year will be lower than our historical effective rate, as well due to R&D tax credits.

Included in our results for the quarter was amortization of purchased DME intangibles totaling $800,000. We are still in the process of finalizing the valuation report for the intangibles, but expect the quarterly run rate for the next two quarters to be at approximately this level.

In 2010, we expect the amortization to be substantially lower, roughly $1.1 million, based on the current preliminary intangible report as this amortization rate for some of the intangibles is very front-end loaded in terms of its value.

Our interest expense for the quarter was approximately $500,000. I expect our overall interest rate to run between 4% and 4.5% over the next two quarters. It is a little higher than in the past two quarters as $17 million -- an interest rate swap for $17 million becomes effective in October that fixes a portion of our five-year term debt at 2.1%, plus the bank spread. Whereas, we are currently accruing interest on that note at 30-day LIBOR, which is running below 50 basis points. That is going to be fixed starting in October at 2.1% plus the bank spread.

We currently have interest rates at about -- interest rates on about $25 million of our debt locked in through either interest rate swaps or stated fixed rates for those debts. The blended rate on those notes is about 5.5%. And that is for our fixed rate debt.

Cash flow has been good over the past six months. We have generated about $9.5 million from operations thus far this year. About $2 million through reductions in our investment in working capital and the balance primarily in profits plus non-cash expenses. We have reduced our CapEx spending this year. Year-to-date, we have invested about $1.5 million in equipment and we expect the 2009 total to be roughly $3.5 million to $4 million.

We have done a lot of belt-tightening across the Company over the past six to nine months. Excluding DME, our headcount is down about 17% from the third quarter of 2008. This, along with many other initiatives across each of our operations, has helped to reduce our operating costs.

Our engineering and development spending included in cost of sales was $6.4 million for the year or for the quarter, excuse me. The organic Astronics business is running at a little over $5 million per quarter and the acquired DME business did a little over $1 million per quarter. We expect to continue in that $6 million to $6.5 million range per quarter for the balance of the year. Pete?

Turning to a discussion of some of our segments and products, I will start with the test systems segment. And before I even get into it, I want to try to clarify something that I think some people might be a little bit confused about and that is when we talk about our DME acquisition, we can talk about it in a number of different ways. You might remember that DME, when we bought it, had two operations. A bigger one that is involved in military test systems and today makes up our test systems segment and a smaller one, which was involved in airport lighting and the aircraft lighting and aircraft safety products.

The bigger one at the time was about a $60 million business. The smaller one was about a $20 million business, so when we talk about organic sales like I was earlier in this call and we remove DME sales, we are removing sales from previous periods from both those operations.

Once we made the acquisition, we took the smaller business and moved it organizationally so that it reports through our aircraft side and today, it is part of our aircraft aerospace segment. The other part of DME makes up our test systems segment. But today, when we talk about DME from a strategy standpoint typically, we are only talking about the test systems segment and the test business. So we have seen some confusion when people try to model the revenue numbers and the sales numbers and the expected profit performance. Hopefully, that clarifies it a little bit. The test systems segment is made up of the Orlando DME business alone without the Fort Lauderdale business.

Revenues in the first half were $17 million, about 18% of total. The financial performance of that business is, on an operating basis, essentially breakeven, which isn't totally disappointing to us given the purchase accounting realities and the fact that the sales level has dropped so much compared to what it was at last year.

Bookings are perhaps the bigger concern. Bookings for that segment so far this year are about $9 million with a backlog of $23.7 million. However, our belief and our conviction is that the business faces some very good prospects and has its sights set on some very good targets. Awards that we expected to be placed by now have not been placed for whatever reason. We can speculate why, but the reality is that the primary customer for that business, the Marine Corps, US Marine Corps, has just moved more slowly than we expected it to at the beginning of the year.

We still believe that there is very good potential there and in fact, in our '09 sales forecast, which we will talk about more in a minute, we are expecting revenues on the positive side of $45 million for that business. So we are expecting the test systems segment obviously to pick up quite a bit of momentum in the second half of the year. We can come back and talk a little bit more about that I am sure in the question-and-answer period.

The aerospace segment had revenues of $80 million in the first half compared to $89 million in the first half of 2008, a reduction of 10%. Again, the smaller part of DME contributed $7.3 million to our current year aerospace segment sales. Margin pressure has resulted from lower volume in all of the operations across that segment resulting in an operating profit of 4.9% versus 13.6%. If you look at our major markets for aerospace, the commercial transport market has taken a little bit of a turn for the worse here as the year has worn on with sales down 16% year-to-date compared to the first half of last year.

Most of this, our little program slides out to the right, our biggest customer, Panasonic, has had year-to-date sales above $18.2 million. For the first half of last year, they had sales of $22.3 million. So they account for some portion of the slide, but by no means all of it.

Business jet sales have taken a dramatic drop, which isn't surprising to anyone who follows the aerospace industry. Our business jet sales are down 39% year-to-date compared to the first half of last year. Again, the first half of last year were record boom times for the business jet industry. Business jet sales make up 12% of our total sales so far this year.

The bright spot is the military side. Sales are up 22% year-to-date compared to this time last year. A lot of that is on the strength of a tactical Tomahawk program that we have. That is a cruise missile and major other programs that we participate in in the military side include the V-22 and the Joint Strike Fighter, which is in the middle stages of development at this point.

For our aerospace segment, we are expecting sales at the end of the year to be on the positive side of $160 million. Putting it all together, our current revenue expectations for the year are in the range of $200 million to $210 million. That compares to last year's total of $174 million. Obviously, we are expecting our organic sales to be down compared to last year. We are expecting consolidated DME revenues from both operations to be in the range of $64 million this year.

Our current revenue expectation of $200 million to $210 million is a slight downward revision from our most recent revenue forecast of $210 million to $225 million and those who look back will remember that, at the beginning of the year, we thought it was going to be in the neighborhood of $230 million to $245 million.

It's a pretty drastic reduction. Over the course of six months, it continues to show the effects that we are dealing with in the market. In our last conference call, I talked about three things that really needed to happen for our forecast for this year to become a reality. One is we needed to have some stability in the commercial transport market. At the end of the first quarter, we felt things looked pretty stable. They have started to slide more than we anticipated through the second quarter.

Perhaps the biggest headline that people are aware of is the 787 moving out. That doesn't help things, but there are lots of other little things that have moved a little bit to the right that cumulatively have had quite an effect on us.

I also said that DME needed to have some timely bookings and by DME in this sense I mean the Orlando business, our test systems segment. And as I said earlier, we think there are some very good prospects out there and there are some promising developments in work right now. It is just a little bit too early for us to talk about those, but we are anticipating positive news on that front in the near future here.

The third thing I said that we needed to do was manage our cost structure and I think we have done that fairly prudently. We continue to do it. We are not in a stable situation and we are as eager for news as everyone else is as to how the overall economy is doing and how that is going to play out for the airlines and the airframe manufacturers and for business jets in particular. We are beginning to see some stability it seems in the business jet world, but it is still very difficult times for the major manufacturers.

So I think that ends my prepared comments. I would like to open it up for questions at this point, Everett.

(Operator Instructions). Tyler Hojo, Sidoti & Co.

Good afternoon, guys, how are you?

Good, Tyler, you?

Good, thanks. I guess definitely understand what is going on with DME here, but a little bit of clarification I think might be in order just in regards to when do you actually need to get these orders to basically execute your sales forecast as you kind of laid it out to us?

Sooner is better than later. We are beginning to bump up into that forecast. I would say as long as we get what we expect to get say by the end of August, we should be okay.

Is there any way you could maybe give us a little bit more color just in regards to what it is you are expecting to get or --? Obviously the Viper/T is out there, but if there is anything else that you could maybe point us to to keep an eye on that. That would be helpful

I am not sure I can do that, Tyler. There are competitive situations and we believe we are very well-positioned, but it is not something that is firm in the bag at this point, so I can't really talk about it.

Okay. Look for something by August and if not, then --?

If you don't see a headline by August, we are going to have to revisit that sales forecast.

Okay, that's fair. And I guess could you maybe just -- I mean I think with DME, you guys were originally thinking 75 to 80 and you have obviously adjusted it down here, but -- I mean when you bought this business, I mean what has kind of gone wrong here or has anything gone wrong or is this really just a timing issue as you see it today?

We see it more as a timing issue. The impression we get is we are not being treated uniquely, but our competitors, by and large, seem to be in the exact same boat. It is not as though there has been a budget freeze that we are aware of or a reduction in funds available. It seems like, for whatever reason, there is just a reluctance to let orders go. It is just that the services have been slow getting orders out there. We have been told that the programs remain intact and they are funded and they want to place orders. So we believe it is a timing issue.

Now there is one thing in there that was a little bit of a surprise to us and that is that we expected a 2009 follow-on Viper/T hardware order, which we believe is still coming, but it is going to be quite a bit smaller and quite a bit later than we thought it was going to be originally. The idea is that they buy this test hardware and they will buy annual buys or they will make multiyear buys over a long period of time and for whatever reason, the normal annual cycle took a hiccup this year. But it is still a piece of hardware that they are using and standardized on and they are going to need more, we believe. It is a question of when they buy it.

But the real issue for success in that business for us is to continue to develop new technologies and not only for the Marine Corps, which is our biggest customer by far, but ideally develop technologies, which will get us into the other armed services. We believe we are doing that and part of the programs that I am kind of cryptically talking around involve technologies that we think are going to be very successfully ported into other armed services and indeed other countries as time progresses here. So hopefully, we will be able to talk about that much more clearly in our next conference call.

Okay, understood. And just one more from me. Obviously, on the cost side, I think you guys alluded to taking about $6 million in annualized costs out of the business. I mean are you pretty much cut to the bone here or is there a possibility where we could see some additional headcount reductions as we move through the year?

Well, I guess two answers to that. One is that, on the direct side, we have to maintain a staffing level to do the work that we need to do. So obviously there are limitations there. Hopefully, we don't see too many more reductions there because that would mean we see a reduction in demand. We don't want to see that.

But the reality is that a big part of our business is overhead and intellectual property and in a time like this, it becomes a little bit of a guessing game. We can make the Company really, really profitable pretty quickly if we want to, but we are trying to manage our cost structure for the downside and yet maintain the things we need to maintain to make sure we come out with the same momentum, if not greater momentum than we had originally when the markets recover.

So that is a little bit of a guessing game, but we are trying to say as close as we can to our customers and find out what their needs are and what their expectations are and how they are managing their business because, obviously, it doesn't do us any good or them any good to be, for example, developing technologies that they don't have the capability to even investigate based on how they are managing their business.

So it is a little bit of a guessing game and we feel like we are trying to do a middle-of-the-road kind of thing where we are managing our cost structure to be responsible given the demand that we are seeing and yet being responsible to our future possibilities and future opportunities by maintaining our intellectual capability and our intellectual talent.

Understood. All right, great. Thanks for all that color.

Sure.

Michael Ciarmoli, Boenning & Scattergood.

Hey, guys Good afternoon. Thanks for taking my call. Just to follow up, Pete, on the DME, talking about these bookings, do you actually have to win a competitive bake-off first to get these bookings or are these going to be DME bookings orders that are just delayed? Is there a competition that has to be won first?

Usually, yes. The Viper/T follow-ons would, obviously, come to us because we are the only provider of those and that is a big part of the business historically over the last couple of years. We expect that will be going forward, but most of the newer technologies or even the test -- what we call test program sets -- that is the hardware-specific test system that runs on Viper/T, those are competitively won.

Okay. Okay. And is the bulk of the bookings that you need related to those?

The ones that we are expecting to drive us for the rest of the year here and into next year, yes, they are competitive.

Okay, that's helpful. And then could you just give us an update. I know the -- and maybe this is bundled in there -- the ground radio maintenance and test system, is that part of the booking you guys are looking for or is that more of a next-generation opportunity?

That is both. That is a next-generation and it is a program we are pursuing.

Okay, okay. And is that award still on track? I think it was for late summer. Is that kind of --?

It is one of the ones that keeps sliding.

Okay, okay. All right, that's helpful. And then just if we can get on to the qual side of the business, I mean headcount coming down. I look at the business, you guys have acquired DME, you have an additional facility there. How many manufacturing facilities to you guys presently have and is there any room to or any possibility that you could consolidate some of your manufacturing?

We have six operations and I look at it as one of those things that we could do. We are all a product of our past experience. I have gone through some really, really bad consolidations and I guess my personal bias is that it is much easier to achieve those -- or it is much easier to calculate those kind of synergies than to actually achieve them. It is a very hard thing to do. And typically, in my experience, unless you have a big organization taking over a smaller organization that does very, very similar things, what you're going to do is lose momentum in what both organizations are trying to achieve. So we are pretty reluctant to go there.

I don't think our facilities themselves are all that elaborate or all that expensive. We have one in -- anything close to Seattle tends to be pretty expensive. All of our other operations tend to be pretty reasonably priced. My own personal bias is that the costs of consolidation or more specifically the risk of consolidation doesn't justify the gains.

Okay. But you guys still have pretty much a significant amount of unused capacity at your Aurora facility, East Aurora where you have done the facility expansion?

We do. I would tell you we have quite a bit of capacity at this point unfortunately in all of our locations.

Okay, okay. So then even with that said, you would be unwilling to kind of go out there and try for that consolidation just given the risks maybe?

Yes, I would view that as a desperate step that we are not close to at this point.

Okay, fair enough. Fair enough. That's helpful. And then just one more. You guys talked about the current backlog. I guess you have -- $73 million of that backlog is shippable in the second half of the year. How much Panasonic revenue is baked into that?

I don't think much, but we tend to have multiyear -- Mark, I am going to turn this to you in a second, but we have multiyear agreements with Panasonic and then I think we recognize bookings on a very limited basis.

Okay, okay.

Do you want to confirm that, Mark?

Yes, that's correct, but I would expect that the second half would look pretty similar to the first half as far as orders go.

In terms of shipments, but it is not a big part of our backlog. That is your question, right?

Okay. So then it would be fair to say -- I mean if I add that backlog that is shippable, that basically gets you to $170 million. Even if I am cautious and say that the Panasonic falls from $18 million down to $15 million, you are essentially at $185 million for the year. So I guess then it really is going to be those DME bookings that gets you the full way there to that $200 million?

I see. So you are taking our actual first half and scheduled backlog and Panasonic bookings?

Right.

Yes, that's right. But there's also quite a few other things that come in and are shipped pretty quickly in various parts of our business.

Okay, okay, that's helpful. Thanks a lot, guys.

Sure.

(Operator Instructions). Dick Ryan, Dougherty.

Thank you. Say, Peter, it sounds like you are keeping the E&D spending relatively constant. Did I catch that correctly?

That's correct.

Okay. Can you talk a little bit about, and I think you did in some past conference calls, some of the new product efforts underway and the kind of progress you are seeing there?

Sure. A fair amount of it is contractually committed to various customers and we think are very worthwhile programs. One of the big ones is the electrical systems for the Lear 85 business jet. We are doing everything from the generators to all the final subsystems, which is similar to what we did on the Eclipse airplane, but it is a next generation, it is higher reliability and this particular airplane is three or four times as big, so it is quite a bit more complex. And that is probably close to a quarter of our total plan for this year all by itself.

Joint Strike Fighter is another one. Next-generation Superiority Fighter by Lockheed, where we are doing the exterior lighting system and the control electronics for the exterior and for the cockpit. Those are two examples that probably get us about halfway there. If you look at the total of our forecast or of our plan, let's say it is $21 million or something, I would suggest to you that $16 million or $17 million of it consists of those types of programs where we are contracted to do something, we have to do it.

In the business jet world, things can change. We are sure hoping at this point that the Lear 85 program is solid. Everything that we are told is that it is. A lot of business jet programs are getting critical reviews these days. You are probably aware that Cessna canceled their Columbus rather unexpectedly a little while ago. So things can happen. But we believe the Lear program is a good program and we think our technology is a good technology. So we are looking at these as things we need to do to be part of this industry, even in these economic times.

Okay, okay. So Dave, on the tax rate, I didn't catch your conversation on the taxes. Did you say we would see it bounce back up towards the second half of the year?

I think for the next -- for the balance of the year, it is going to be down in that lower than typical range as a result of some efforts we are doing to identify some R&D tax credit opportunities.

Okay, okay. Is there anything left from Eclipse inventory-wise?

I don't have the number in front of me. It is the same as it was at year-end and at the end of the first quarter. There has been virtually no activity for that. We ship occasionally odds and ends of some parts to some people, but if my memory is right, it's I want to say a couple hundred thousand dollars, but don't quote me on that, but it hasn't changed much since year-end.

Okay. So, Pete, could you talk about how much Viper/T was, how much contribution Viper/T was to the DME on the test side?

So far this year?

Yes.

I don't have that. Do you have that?

No, in front of us, we don't have the breakout by program.

Okay. What was it historically? I mean when you acquired it, what --?

Big. I would say it's at least half. Probably half of the Orlando revenue over the last couple of years has been Viper/T.

Okay. Great. Thank you.

And it could well be in that range this year too. I just don't have it in front of me.

Sure. Sure. Okay, thanks.

Michael Ciarmoli, Boenning & Scattergood.

Hey, guys, thanks. I just had one quick follow-up. I am sure I missed this; in fact, I think I did. What was the tax rate you guys were expecting for the second half of the year or full year?

Expecting currently or in the past?

No, your tax rate that you are expecting for 2009, do you have that or no?

It is a little difficult because we have an ongoing effort to review and identify R&D tax credit opportunities right now that is still in process. So what we saw in the second quarter being recorded or what we have identified and we are still in the process of looking at some other programs and opportunities there, but my guess is it is going to be below 30%, probably above 25%. It is really hard -- that's a really, really wild guess though because I don't have the full report completed yet on the R&D tax credit.

Okay. That's helpful. Thank you, guys.

Scott Lewis, Lewis Capital Management.

Thanks, good afternoon, guys. Just a couple of questions about the cabin electronics. For the new airplane market, are you guys doing everything pretty much now through the IFE guys or do you talk to airlines directly anymore? And I wanted to ask kind of what the competitive situation is there if you do talk to the airlines?

We definitely talk to the airlines. We have the same kind of sales group we had in place years ago, practically speaking and they are doing the same kinds of things. So we are out at trade shows, out in the airlines and at the airframe guys in addition to our IFE customers. We feel like, if anything, we are even more strongly positioned competitively than before.

For those unfamiliar, we have a single competitor really in that product area who is in Germany and owned by Airbus and the technical developments in that market have been led by us really over the last four years, five years and have not been responded to very comprehensively. And we don't win everything at this point, but the reduction that you see in our commercial transport or cabin electronic sales are purely driven by the market, not necessarily due to competitive losses at all, if that is what you are asking about.

That is what I was asking about. And is the retrofit market any different competitively or is it the same market basically?

It is the same competitor, the same customer and the same market. Most people think of -- we look at the retrofit market really as very similar to the new aircraft market. It is the same kind of sale, it is the same kind of ultimate customer. Not a whole lot different and it is the same competitor. So we are seeing some slowdown there. The airline struggles are pretty well-publicized. They haven't changed a whole lot and again, I think competitively we continue to be very well-positioned. It is just that the market has been a little bit slower than it was this time last year.

Right, okay. Thanks a lot, Pete.

Ladies and gentlemen, we have no further questions at this time. I would like to turn the floor back to management.

Very good. Thanks, Everett and thanks, everybody, for tuning in. We appreciate your interest in Astronics and we look forward to talking to you again next time. Thanks.

Ladies and gentlemen, this concludes today's teleconference. You may disconnect your lines at this time. Thank you for your participation.